Topic: High-throughput screening

Support for academic researchers to conduct high-throughput screening using AstraZeneca’s compound library and screening infrastructure. The January 2027 round is open to all targets and provides awards up to GBP270,000. Projects must be directed by an eligible research lead actively engaged in the work. Commercial-led applications and collaborations involving additional commercial parties are excluded. Apply through UKRI’s Funding Service by 28 January 2027 at 16:00 UK time.